Detalhe da pesquisa
1.
Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM-3 antibody, in combination with decitabine or azacitidine in high- or very high-risk myelodysplastic syndromes.
Am J Hematol
; 99(2): E32-E36, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37994196
2.
Chemotherapy Resistance in B-ALL with Cryptic NUP214-ABL1 Is Amenable to Kinase Inhibition and Immunotherapy.
Oncologist
; 27(2): 82-86, 2022 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35641210
3.
Two In Cis Variants-Two Worlds Apart.
Oncologist
; 26(12): 997-999, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407276
4.
A phase 1 study of the antibody-drug conjugate brentuximab vedotin with re-induction chemotherapy in patients with CD30-expressing relapsed/refractory acute myeloid leukemia.
Cancer
; 126(6): 1264-1273, 2020 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31860140
5.
Donor-Derived Cytokine-Induced Killer Cell Infusion as Consolidation after Nonmyeloablative Allogeneic Transplantation for Myeloid Neoplasms.
Biol Blood Marrow Transplant
; 25(7): 1293-1303, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30951840
6.
Zoledronic acid-induced orbital inflammation in a patient with multiple myeloma.
J Oncol Pharm Pract
; 25(5): 1253-1257, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30005587
7.
T-Cell Immunopeptidomes Reveal Cell Subtype Surface Markers Derived From Intracellular Proteins.
Proteomics
; 18(12): e1700410, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29493099
8.
Multiple clinical forms of dehydrated hereditary stomatocytosis arise from mutations in PIEZO1.
Blood
; 121(19): 3925-35, S1-12, 2013 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-23479567
9.
First-in-human study of JNJ-67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome.
Clin Transl Sci
; 17(3): e13742, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38494922
10.
HLA Class I Genotype Is Associated with Relapse Risk after Allogeneic Stem Cell Transplantation for NPM1-Mutated Acute Myeloid Leukemia.
Transplant Cell Ther
; 29(7): 452.e1-452.e11, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36997024
11.
Enasidenib as maintenance following allogeneic hematopoietic cell transplantation for IDH2-mutated myeloid malignancies.
Blood Adv
; 6(22): 5857-5865, 2022 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36150050
12.
A nonrandomized phase I and biomarker trial of regorafenib in advanced myeloid malignancies.
EJHaem
; 3(2): 434-442, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35846042
13.
Arsenic toxicity manifesting as profuse watery diarrhea during induction therapy for acute promyelocytic leukemia.
Clin Case Rep
; 9(5): e04115, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34026155
14.
Modified Hyper-CVAD With Proteasome Inhibition for Multiple Myeloma: A Single-Center Retrospective Analysis.
Clin Lymphoma Myeloma Leuk
; 20(12): e961-e985, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32839138
15.
Incidence of Invasive Fungal Infections in Acute Myeloid Leukemia Without Antifungal Prophylaxis.
Clin Lymphoma Myeloma Leuk
; 20(11): e883-e889, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32917574
16.
Clinical response to larotrectinib in adult Philadelphia chromosome-like ALL with cryptic ETV6-NTRK3 rearrangement.
Blood Adv
; 4(1): 106-111, 2020 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31905241
17.
Acute myeloid leukemia immunopeptidome reveals HLA presentation of mutated nucleophosmin.
PLoS One
; 14(7): e0219547, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31291378
18.
Sequential azacitidine plus lenalidomide in previously treated elderly patients with acute myeloid leukemia and higher risk myelodysplastic syndrome.
Leuk Lymphoma
; 57(3): 609-15, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26374199
19.
Targeted FGFR inhibition results in a durable remission in an FGFR1-driven myeloid neoplasm with eosinophilia.
Blood Adv
; 4(13): 3136-3140, 2020 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32649766
20.
Cardiac and genetic predictors of cardiovascular risk in patients with myelodysplastic syndromes.
Leuk Lymphoma
; 60(12): 3058-3062, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31120366